Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Peptides
|
November 1, 1990
Expression of recombinant human glucose-dependent insulinotropic polypeptide in Escherichia coli by sequence-specific proteolysis of a protein A fusion protein
B K Chow, G W Morrow, M Ho, et al.
Canadian Journal of Physiology and Pharmacology
|
January 1, 1996
The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30
G W Morrow, T J Kieffer, C H McIntosh, et al.
Advances in Experimental Medicine and Biology
|
June 13, 2000
Analogs of glucose-dependent insulinotropic polypeptide with increased dipeptidyl peptidase IV resistance
K Kühn-Wache, S Manhart, T Hoffmann, et al.
Diabetes
|
July 2, 1998
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice
R A Pederson, M Satkunarajah, C H McIntosh, et al.
The Journal of Biological Chemistry
|
August 24, 1999
Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization
M B Wheeler, R W Gelling, S A Hinke, et al.
Metabolism: Clinical and Experimental
|
March 27, 1999
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide
R P Pauly, H U Demuth, F Rosche, et al.
Diabetes Care
|
October 27, 2001
Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes
G S Meneilly, C H McIntosh, R A Pederson, et al.
The Journal of Biological Chemistry
|
February 8, 2000
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs
S A Hinke, J A Pospisilik, H U Demuth, et al.
Endocrinology
|
January 14, 1999
Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin
C H McIntosh, I Bremsak, F C Lynn, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
August 29, 2001
Effect of aging and diabetes on the enteroinsular axis
J Korosi, C H McIntosh, R A Pederson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Peptides
|
November 1, 1990
Expression of recombinant human glucose-dependent insulinotropic polypeptide in Escherichia coli by sequence-specific proteolysis of a protein A fusion protein
B K Chow, G W Morrow, M Ho, et al.
Canadian Journal of Physiology and Pharmacology
|
January 1, 1996
The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30
G W Morrow, T J Kieffer, C H McIntosh, et al.
Advances in Experimental Medicine and Biology
|
June 13, 2000
Analogs of glucose-dependent insulinotropic polypeptide with increased dipeptidyl peptidase IV resistance
K Kühn-Wache, S Manhart, T Hoffmann, et al.
Diabetes
|
July 2, 1998
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice
R A Pederson, M Satkunarajah, C H McIntosh, et al.
The Journal of Biological Chemistry
|
August 24, 1999
Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization
M B Wheeler, R W Gelling, S A Hinke, et al.
Metabolism: Clinical and Experimental
|
March 27, 1999
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide
R P Pauly, H U Demuth, F Rosche, et al.
Diabetes Care
|
October 27, 2001
Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes
G S Meneilly, C H McIntosh, R A Pederson, et al.
The Journal of Biological Chemistry
|
February 8, 2000
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs
S A Hinke, J A Pospisilik, H U Demuth, et al.
Endocrinology
|
January 14, 1999
Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin
C H McIntosh, I Bremsak, F C Lynn, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
August 29, 2001
Effect of aging and diabetes on the enteroinsular axis
J Korosi, C H McIntosh, R A Pederson, et al.
Page
of 9